Share
Search
result
Bringing A/I to the National Healthcare Conversation as a Member of the National Academy of Medicine (NAM)
Bringing A/I to the National Healthcare Conversation as a Member of the National Academy of Medicine (NAM)
For Marc E. Rothenberg, MD, PhD, FAAAI, being elected to the National Academy of Medicine (NAM) is an honor that allows him to bring the voice of the allergist/immunologist to critical healthcare issues addressed by the prestigious organization.
Marc E. Rothenberg, MD, PhD, FAAAAI
“I am excited to be an ambassador for our field, and to apply our field expertise to the important agenda items and noble efforts of the NAM,” Dr. Rothenberg said. “I’m participating in activities with outstanding leaders in medicine. These activities are focused on many problems facing child health, including climate change, gun violence, declining outcomes of too many diseases in the USA compared with other countries, and so much more.”
Dr. Rothenberg is Director of the Division of Allergy and Immunology and Cincinnati Center for Eosinophilic Disorders at Cincinnati Children’s.
He was elected to NAM in October of 2022, in part due to his efforts to uncover mechanisms and new therapies, which have helped contribute to a new class of drugs (anti-eosinophil therapy). He is the founder/principal investigator of the Consortium of Eosinophilic Gastrointestinal Disease Researchers, which is a consortium of the Rare Diseases Clinical Research Network, where he serves as a member of leadership. He also helped develop the first FDA-approved treatment for an eosinophilic gastrointestinal disorder, dupilumab.
Dr. Rothenberg’s work with NAM includes working with committees “established to provide guidelines, evaluations, and strategic directions on important major topics in medicine and science. I have been most involved in the pediatric section, which was responsible for my election.”
Education is another important part of the work Dr. Rothenberg is doing as part of the NAM. “We’ve had meetings recently about an internal webinar series focused on major issues in pediatrics. Areas of focus typically undergo a deep analysis in terms of their magnitude, impact, and pathway forward, communicated in a detailed written report,” he explained.
NAM is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States. The National Academies are private, nonprofit institutions that work outside of government to provide objective advice on matters of science, technology, and health. Being elected to the NAM is considered to be one of the highest honors in health and medicine and demonstrates an individual has achieved incredible professional achievements, including contributions to the advancement of medicine and commitment to medical service.
“I look forward to interacting with this impressive body of global thought leaders in medicine, and to participating in efforts that will impact the direction of medicine and science in our country and beyond,” Dr. Rothenberg said.
